FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to condensed bicyclic compounds of formula (IX), in which radicals and symbols are defined in the claim, or pharmaceutically acceptable salts thereof. Invention also refers to a pharmaceutical composition containing them, and to a method of treating a disease, disorder or pathological condition in a mammal, which is favourably effected by FXR modulation.
Formula (IX).
EFFECT: these compounds have modulating effect on farnesoid X-receptor (FXR).
17 cl, 1 tbl, 51 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED BICYCLIC COMPOUNDS FOR TREATING DISEASE | 2015 |
|
RU2741387C2 |
| HIMBACINE "НОР СЕКОПРОИЗВОДНЫЕ" WITH INHIBITORY ACTION WITH RESPECT TO THROMBIN RECEPTORS | 2004 |
|
RU2367660C9 |
| METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
| MONOCYCLIC HETEROCYCLES INHIBITING KINASE | 2005 |
|
RU2350603C2 |
| N-REPLACED BENZOSULPHONAMIDES | 2004 |
|
RU2364587C2 |
| PROCESS FOR PHOTOCATALYTIC POLYMERIZATION OF CYCLIC OLEFINS IN PRESENCE OF RUTHENIUM OR OSMIUM CATALYST CONTAINING PHOTOLABILE LIGANDS, COMPOSITION AND COATED CARRIER | 1994 |
|
RU2137783C1 |
| MACROCYCLIC ANTIBIOTICS OF WIDE SPECTRUM OF ACTION | 2016 |
|
RU2761476C2 |
| BICYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | 2018 |
|
RU2776846C2 |
| COMPOSITIONS BASED ON SHP2 INHIBITOR AND METHODS OF CANCER TREATMENT | 2018 |
|
RU2805355C2 |
| SUBSTITUTED BICYCLIC COMPOUNDS, PARENT AND INTERMEDIATE SUBSTANCES FOR THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1998 |
|
RU2203272C2 |
